Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L
Mott DJ, Devlin NJ, Kreimeier S, Norman R, Shah KK, Rivero-Arias O (2022)
PharmacoEconomics .
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Mott, David J.;
Devlin, Nancy J.;
Kreimeier, SimoneUniBi ;
Norman, Richard;
Shah, Koonal K.;
Rivero-Arias, Oliver
Einrichtung
Abstract / Bemerkung
Discrete choice experiments (DCEs) are becoming increasingly used to elicit preferences for children's health states. However, DCE data need to be anchored to produce value sets, and composite time trade-off (cTTO) data are typically used in the context of EQ-5D-Y-3L valuation. The objective of this paper is to compare different anchoring methods, summarise the characteristics of the value sets they produce, and outline key considerations for analysts. Three anchoring methods were compared using data from published studies: (1) rescaling using the mean value for the worst health state; (2) linear mapping; and (3) hybrid modelling. The worst state rescaling value set had the largest range. The worst state rescaling and linear mapping value sets preserved the relative importance of the dimensions from the DCE, whereas the hybrid model value set did not. Overall, the predicted values from the hybrid model value set were more closely aligned with the cTTO values. These findings are relatively generalisable. Deciding upon which anchoring approach to use is challenging, as there are numerous considerations. Where cTTO data are collected for more than one health state, anchoring on the worst health state will arguably be suboptimal. However, the final choice of approach may require value judgements to be made. Researchers should seek input from relevant stakeholders when commencing valuation studies to help guide decisions and should clearly set out their rationale for their preferred anchoring approach in study outputs.
Erscheinungsjahr
2022
Zeitschriftentitel
PharmacoEconomics
ISSN
1170-7690
eISSN
1179-2027
Page URI
https://pub.uni-bielefeld.de/record/2967391
Zitieren
Mott DJ, Devlin NJ, Kreimeier S, Norman R, Shah KK, Rivero-Arias O. Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. PharmacoEconomics . 2022.
Mott, D. J., Devlin, N. J., Kreimeier, S., Norman, R., Shah, K. K., & Rivero-Arias, O. (2022). Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. PharmacoEconomics . https://doi.org/10.1007/s40273-022-01214-x
Mott, David J., Devlin, Nancy J., Kreimeier, Simone, Norman, Richard, Shah, Koonal K., and Rivero-Arias, Oliver. 2022. “Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L”. PharmacoEconomics .
Mott, D. J., Devlin, N. J., Kreimeier, S., Norman, R., Shah, K. K., and Rivero-Arias, O. (2022). Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. PharmacoEconomics .
Mott, D.J., et al., 2022. Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. PharmacoEconomics .
D.J. Mott, et al., “Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L”, PharmacoEconomics , 2022.
Mott, D.J., Devlin, N.J., Kreimeier, S., Norman, R., Shah, K.K., Rivero-Arias, O.: Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. PharmacoEconomics . (2022).
Mott, David J., Devlin, Nancy J., Kreimeier, Simone, Norman, Richard, Shah, Koonal K., and Rivero-Arias, Oliver. “Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L”. PharmacoEconomics (2022).
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 36396877
PubMed | Europe PMC
Suchen in